Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

Share Price is delayed by 15 minutes
Get Live Data
913.00    17.00 (1.90%)
Bid:
913.00
Ask:
914.00
Spread: 1.00 (0.11%)
Market Cap: £131.36b
BNC Live PriceLast checked at - London Stock Exchange

Intraday Banco Santander Share Chart

Buyback programme: transactions 20Feb-26Feb

27 Feb 2025 11:12

RNS Number : 7376Y
Banco Santander S.A.
27 February 2025
 

Banco Santander, S.A. (the "Bank" or "Banco Santander"), in compliance with the Securities Market legislation, hereby communicates the following:

OTHER RELEVANT INFORMATION

Reference is made to our notice of inside information of 5 February 2025 (official registry number 2584) (the "Buy-back Commencement Communication"), relating to the buyback programme of own shares (the "Buy-back Programme") approved by the Board of Directors of Banco Santander.

 

Pursuant to article 5 of Regulation (EU) no. 596/2014 on Market Abuse of 16 April 2014, and articles 2.2 and 2.3 of Commission Delegated Regulation (EU) 2016/1052, of 8 March 2016, the Bank informs of the transactions carried out over its own shares between 20 and 26 February 2025 (both inclusive).

 

The cash amount of the shares purchased to 26 February 2025 as a result of the execution of the Buy-back Programme amounts to 280,829,090 Euros, which represents approximately 17.7% of the maximum investment amount of the Buy-back Programme. The programme was announced together with its other characteristics through the Buy-back Commencement Communication. With these purchases, the Bank has repurchased approximately 12.9% of its outstanding shares as of 2021.

 

Date

Security

Transaction

Trading venue

Number of shares

Weighted average price (€)

20/02/2025

SAN

Purchase

XMAD

1,578,462

5.8631

20/02/2025

SAN

Purchase

CEUX

480,461

5.8827

20/02/2025

SAN

Purchase

TQEX

129,902

5.8803

20/02/2025

SAN

Purchase

AQEU

311,175

5.8769

21/02/2025

SAN

Purchase

XMAD

1,495,823

5.8587

21/02/2025

SAN

Purchase

CEUX

482,339

5.8511

21/02/2025

SAN

Purchase

TQEX

199,868

5.8580

21/02/2025

SAN

Purchase

AQEU

221,970

5.8496

24/02/2025

SAN

Purchase

XMAD

1,524,089

5.9584

24/02/2025

SAN

Purchase

CEUX

486,660

5.9494

24/02/2025

SAN

Purchase

TQEX

159,517

5.9451

24/02/2025

SAN

Purchase

AQEU

229,734

5.9569

25/02/2025

SAN

Purchase

XMAD

1,163,263

6.0451

25/02/2025

SAN

Purchase

CEUX

710,554

6.0578

25/02/2025

SAN

Purchase

TQEX

255,333

6.0573

25/02/2025

SAN

Purchase

AQEU

370,850

6.0633

26/02/2025

SAN

Purchase

XMAD

1,457,456

6.1654

26/02/2025

SAN

Purchase

CEUX

619,503

6.1623

26/02/2025

SAN

Purchase

TQEX

144,192

6.1514

26/02/2025

SAN

Purchase

AQEU

278,849

6.1665

TOTAL

12,300,000

 

Issuer name: Banco Santander, S.A. - LEI 5493006QMFDDMYWIAM13

 

Reference of the financial instrument: ordinary shares - Code ISIN ES0113900J37

 

Detailed information of the transactions carried out within the referred period is attached as Annex I.

 

Boadilla del Monte (Madrid), 27 February 2025

ANNEX I

Detailed information on each of the transactions carried out within the context of the Buy-back Programme between 20/02/2025 and 26/02/2025 (both inclusive)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSSEFFFWEISEFE
Date   Source Headline
6th May 20257:00 amRNSAnalysts meeting announcement
30th Apr 202512:41 pmRNSTotal Voting Rights
30th Apr 20257:00 amRNS1Q 2025 Results report & analyst presentation
30th Apr 20257:00 amRNS1Q 2025 Results Press Release
29th Apr 202511:11 amRNSBuyback programme: Transactions 23-28Apr
28th Apr 20251:56 pmRNSSantander statement
23rd Apr 202511:59 amRNS1st Quarter 2025 Results Notice
23rd Apr 202511:11 amRNSBuyback programme: transactions 11-22Apr
11th Apr 202511:13 amRNSBuyback programme: transactions 3-10Apr
4th Apr 20253:09 pmRNS2025 AGM - Resolutions
4th Apr 20257:08 amRNSSantander expects growth & 2025 targets reaffirmed
3rd Apr 202511:13 amRNSBuyback programme: transactions 27Mar-2Apr
31st Mar 20254:07 pmRNSTotal Voting Rights
27th Mar 202511:15 amRNSTransaction in Own Shares
20th Mar 202511:10 amRNSBuyback programme: transactions 13Mar-19Mar
17th Mar 20255:31 pmRNSDirector/PDMR Shareholding
14th Mar 20251:27 pmRNSDirector/PDMR Shareholding
14th Mar 20251:22 pmRNSDirector/PDMR Shareholding
13th Mar 202511:06 amRNSBuyback programme: transactions 6 Mar -12 Mar
6th Mar 202511:14 amRNSBuyback programme: transactions 27 Feb- 5 Mar
5th Mar 20257:00 amRNSDirector/PDMR Shareholding
5th Mar 20257:00 amRNSDirector/PDMR Shareholding
28th Feb 20256:23 pmRNSDirector/PDMR Shareholding
28th Feb 20256:19 pmRNSDirector/PDMR Shareholding
28th Feb 20256:14 pmRNSDirector/PDMR Shareholding
28th Feb 20256:08 pmRNSDirector/PDMR Shareholding
28th Feb 202510:52 amRNSTotal Voting Rights
28th Feb 202510:51 amRNSNotice of AGM
28th Feb 202510:15 amRNS2024 UK Annual Report
27th Feb 202511:12 amRNSBuyback programme: transactions 20Feb-26Feb
26th Feb 20257:00 amRNSDirector/PDMR Shareholding
26th Feb 20257:00 amRNSDirector/PDMR Shareholding
26th Feb 20257:00 amRNSDividend declaration & agreement to call 2025 AGM
20th Feb 202511:12 amRNSBuyback programme: transactions 13Feb-19Feb
19th Feb 20255:46 pmRNSDirector/PDMR Shareholding
14th Feb 20251:10 pmRNSReplaces Invitation to purchase certain instrument
13th Feb 202512:00 pmRNSInvitation to purchase certain instruments
13th Feb 202511:18 amRNSBuyback programme: transactions 6Feb-12Feb
12th Feb 20253:43 pmRNSRating granted by Fitch Ratings
7th Feb 20251:49 pmRNSDirector/PDMR Shareholding
7th Feb 20251:48 pmRNSDirector/PDMR Shareholding
6th Feb 20258:00 amRNSInvitation to purchase certain instruments
5th Feb 20257:00 amRNS2024 Financial report & Earnings presentation
5th Feb 20257:00 amRNS2024 Results - Press release
5th Feb 20257:00 amRNSCommencement of a program to repurchase own shares
31st Jan 20251:14 pmRNSTotal Voting Rights
29th Jan 202512:44 pmRNSForm 8.3 - Smith (DS) PLC
29th Jan 202511:07 amRNSNotice of 2024 Results Presentation
23rd Jan 20254:03 pmRNSInvitation to purchase certain instruments
20th Jan 20259:28 amRNSOptional early redemption ISIN XS1793250041

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.